Reports for RISPERIDONE
Ingredient
RISPERIDONE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-09-22 | 2023-12-01 | 205002 |
| JAMP-RISPERIDONE | 1MG | SOLUTION | Actual shortage | 2023-10-18 | 2023-11-15 | 207292 |
| PMS-RISPERIDONE | 1MG | SOLUTION | Resolved | 2023-10-30 | 2024-03-16 | 208577 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-11-10 | 2024-04-26 | 209957 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-12-22 | 2024-05-03 | 214247 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2024-03-01 | 2024-04-26 | 221090 |
| RISPERIDONE | 0.25MG | TABLET | Resolved | 2024-03-25 | 2024-05-17 | 223270 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223543 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118159 |
| SANDOZ RISPERIDONE | 3.0MG | TABLET | Discontinued | 2021-03-22 | 2021-03-22 | 136095 |
| SANDOZ RISPERIDONE | 1.0MG | TABLET | Discontinued | 2021-08-19 | 2021-08-19 | 144338 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| RISPERDAL ORAL SOLUTION | 1MG | SOLUTION | To be discontinued | 2023-04-27 | 2023-04-27 | 190894 |